Vorinostat Completed Phase 2 Trials for Malignant Gliomas / Adult Brain Tumors / Recurrent Glioblastoma Multiforme Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01738646Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients